Inside the Reproductive Sciences Lab at the University of Colorado Anschutz Medical Campus in Aurora, researchers are on the ...

A U.S. bankruptcy judge has denied Johnson & Johnson's settlement plan relating to its baby powder products containing talc.

Inside the Reproductive Sciences Lab at the University of Colorado Anschutz Medical Campus in Aurora, researchers are on the ...

A judge rejected Johnson & Johnson’s talcum powder bankruptcy proposal, allowing talc ovarian cancer lawsuits to proceed in ...

A new drug tested in a phase 3 trial showed significant improvement in patients with treatment-resistant ovarian cancer.

Shares of Johnson & Johnson ( JNJ -6.57%) are tumbling on Tuesday. The company's stock lost 6.3% as of 2:25 p.m. ET. The drop ...

A second phase 1 trial plans to evaluate CER-1236, a novel chimeric antigen receptor therapy, for solid tumors.

Johnson & Johnson’s plan to settle thousands of talc-related lawsuits through bankruptcy was shot down in court.

A U.S. bankruptcy judge ruled against the company's attempt to settle tens of thousands of claims alleging its talc products ...

Corcept's relacorilant hits phase 3 trial success in ovarian cancer, lifting shares 90%. Click here to find out why I rate ...

A Houston bankruptcy judge has rejected Johnson & Johnson’s to use federal bankruptcy procedures to force a settlement with ...